April 1, 2025 - 07:44

Pat Geraghty, the longtime top executive of one of the nation’s fastest-growing health insurance companies, Florida Blue, will retire at the end of this year. Geraghty has led the company through significant transformations and expansion, positioning it as a leader in the health insurance market.
Under his leadership, Florida Blue has seen substantial growth and innovation, adapting to the ever-changing landscape of healthcare. His tenure has been marked by a commitment to improving access to healthcare services and enhancing the overall customer experience. Geraghty has emphasized the importance of community engagement and has been instrumental in initiatives aimed at addressing health disparities across Florida.
As the company prepares for this transition, the board of directors is expected to begin the search for a successor who can continue the momentum that Geraghty has built over the years. His retirement marks the end of an era for Florida Blue, leaving behind a legacy of growth and a strong foundation for future leadership.
December 15, 2025 - 04:17
Cassidy Optimistic About Bipartisan Deal on ACA Subsidies by Year-EndSenator Bill Cassidy (R-La.) shared a hopeful outlook on the potential for a bipartisan agreement aimed at extending enhanced Affordable Care Act (ACA) subsidies for specific Americans. Speaking on...
December 14, 2025 - 05:37
Senate's Health Care Votes Fall Short: Key Points to ConsiderThe Senate this week failed to pass dueling bills from Republicans and Democrats aimed at addressing a looming spike in health insurance costs for individuals purchasing Affordable Care Act (ACA)...
December 13, 2025 - 06:07
Unveiling Inspiring Tales of Marathon Runners at the Health and Fitness ExpoDiscover the stories and excitement as runners gather at the Health and Fitness Expo for the marathon weekend. This vibrant event brings together athletes from all walks of life, each with their...
December 12, 2025 - 23:33
Health Experts Criticize Potential High-Level Warnings for COVID VaccinesThe FDA is reportedly contemplating the introduction of high-level warning labels for COVID vaccines, a decision that has sparked significant concern among health experts. Many professionals in the...